Literature DB >> 11344351

Mass, charge, and subcellular localization of a unique secretory product identified by the basophil-specific antibody BB1.

A R McEuen1, J Calafat, S J Compton, N J Easom, M G Buckley, E F Knol, A F Walls.   

Abstract

BACKGROUND: BB1 is a basophil-specific mAb (Lab Invest 1999;79:27-38). The identity of the corresponding antigen has not been determined, but it gives a granular appearance on staining and is secreted on activation of basophils.
OBJECTIVE: We sought to further characterize the basophilspecific antigen identified by BB1.
METHODS: Intracellular localization was determined by flow cytometry and by immunogold labeling and electron microscopy. Physical chemical properties were investigated by gel filtration chromatography and preparative isoelectric focusing.
RESULTS: In flow cytometry, permeabilization of cells increased immunofluorescence 100-fold, confirming the predominantly intracellular localization of the antigen. It was further localized to the secretory granules by immunoelectron microscopy. Double labeling with a CD63-specific antibody demonstrated selective binding of BB1 to the granule matrix. Gel filtration chromatography indicated that the antigen is secreted as a complex of approximately 5 x 10(6) d, which was well resolved from the 210-kd supramolecular complex containing tryptase. The antigen was degraded by pronase. Isoelectric focusing indicated a highly basic protein with an isoelectric point of 9.6.
CONCLUSION: With its granule localization, release on cell activation, and unique properties, the antigen identified by BB1 could be a novel mediator of allergic disease. We propose the name basogranulin for this novel basophil-specific protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344351     DOI: 10.1067/mai.2001.114650

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

Review 1.  Basophils in airway disease.

Authors:  Donald MacGlashan; Gail Gauvreau; John T Schroeder
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

2.  Basophils are increased and express increased levels of interleukin-4 in the parotid lesions of Kimura disease.

Authors:  Manabu Nonaka; Eri Sakitani; Erika Ono; Yukie Yamamura; Yukako Seo; Noriyuki Shibata; Ruby Pawankar; Toshio Yoshihara
Journal:  Asia Pac Allergy       Date:  2017-10-23

Review 3.  Behind the scenes with basophils: an emerging therapeutic target.

Authors:  Hemali Shah; Stephanie Eisenbarth; Christopher A Tormey; Alexa J Siddon
Journal:  Immunother Adv       Date:  2021-05-19

4.  Human cord blood derived immature basophils show dual characteristics, expressing both basophil and eosinophil associated proteins.

Authors:  Jeanette Grundström; Jenny M Reimer; Sofia E Magnusson; Gunnar Nilsson; Sara Wernersson; Lars Hellman
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

5.  Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils.

Authors:  Anm Nazmul H Khan; Tiffany R Emmons; Jerry T Wong; Emad Alqassim; Kelly L Singel; Jaron Mark; Brandon E Smith; Joseph D Tario; Kevin H Eng; Kirsten B Moysich; Kunle Odunsi; Scott I Abrams; Brahm H Segal
Journal:  Cancer Immunol Res       Date:  2020-04-01       Impact factor: 12.020

Review 6.  Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases.

Authors:  Dean D Metcalfe; Ruby Pawankar; Steven J Ackerman; Cem Akin; Frederic Clayton; Franco H Falcone; Gerald J Gleich; Anne-Marie Irani; Mats W Johansson; Amy D Klion; Kristin M Leiferman; Francesca Levi-Schaffer; Gunnar Nilsson; Yoshimichi Okayama; Calman Prussin; John T Schroeder; Lawrence B Schwartz; Hans-Uwe Simon; Andrew F Walls; Massimo Triggiani
Journal:  World Allergy Organ J       Date:  2016-02-11       Impact factor: 4.084

Review 7.  Is There a Role for Basophils in Cancer?

Authors:  Giancarlo Marone; John T Schroeder; Fabrizio Mattei; Stefania Loffredo; Adriana Rosa Gambardella; Remo Poto; Amato de Paulis; Giovanna Schiavoni; Gilda Varricchi
Journal:  Front Immunol       Date:  2020-09-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.